|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and marketing expenses | |||||
| Administrative expenses | |||||
| Total operating expenses | |||||
| Operating profit | |||||
| Other income, net | |||||
| Finance cost | |||||
| Profit before income taxes | |||||
| Income tax expense | |||||
| Net profit | |||||
| Total comprehensive income attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interests | |||||
| Items that will not be reclassified subsequently to profit or loss: | |||||
| Remeasurements of the net defined benefit liability / asset, net | |||||
| Equity instruments through other comprehensive income, net | |||||
| Other comprehensive income that will not be reclassified to profit or loss, net of tax | |||||
| Items that will be reclassified subsequently to profit or loss: | |||||
| Fair valuation of investments, net | |||||
| Fair value changes on derivatives designated as cash flow hedge, net | |||||
| Exchange differences on translation of foreign operations | |||||
| Total other comprehensive income that will be reclassified to profit or loss, net of tax | |||||
| Total other comprehensive income/(loss), net of tax | |||||
| Total comprehensive income | |||||
| Earnings per equity share | |||||
| Basic (in $ per share) | |||||
| Diluted (in $ per share) | |||||
| Weighted average equity shares used in computing earnings per equity share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Profit attributable to: | |||||
| Owners of the Company | |||||
| Non-controlling interests |
Loading...